Message from Dr. Majeed
Sabinsa Corporation is now in its eighteenth year. We have expanded our range of branded nutraceutical and cosmeceutical ingredients, conducted pioneering clinical research into their efficacy and safety, and built a sizeable intellectual property portfolio.
2006 began well for us. On January 3rd, we were granted a US Patent for a bioavailable composition of methylselenocysteine, a naturally occurring form of the essential trace mineral nutrient, selenium. Quality continues to be our major priority. We recently received certification from NSF International for yet another branded ingredient, Forslean (Sabinsa's patented, award winning Coleus forskohlii Extract).
In an industry posed with a number of regulatory challenges including the impending GMP regulations, our focus has always been on quality and application oriented research. Several standardized extracts that we manufacture and supply, are currently being used in Investigational New Drug (IND) studies in the United States and elsewhere, with approval from the concerned regulatory authorities.
To build a strong and credible image for the industry, both manufacturers of finished products, and suppliers of raw ingredients need to focus on establishing and maintaining quality standards, clinically validating ingredient health claims, and educating consumers on the health benefits of phytonutrients and nutritional materials. I stand firm in the belief that these ingredients will emerge as safe and effective measures, in preventive heath maintenance, and as adjuncts to therapeutics in the treatment of chronic diseases.
As always, we remain caring and committed to the spirit of innovation in preventive healthcare, and will continue to provide the quality ingredients that you have come to expect from SABINSA, this year and in the years to come. I take this opportunity to wish you all a very Happy and Healthy 2006.
